Metairie, LANCT07699471Now EnrollingIRB Ready

Hypoparathyroidism Clinical Trial in Metairie, LA

Access cutting-edge hypoparathyroidism treatment through this phase 3 clinical trial at a research site in Metairie. Study-provided care at no cost to qualified participants.

Sponsored by MBX Biosciences

Quick Self-Assessment

See if you qualify for this Metairie location

Preparing your pre-screening questions…

Expert Care in Metairie

Access hypoparathyroidism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypoparathyroidism treatment provided free

Apply for This Metairie Location

Check if you qualify for this hypoparathyroidism clinical trial in Metairie, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Metairie

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Metairie site if eligible
  4. 4Begin participation

About This Hypoparathyroidism Study in Metairie

The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).

Sponsor: MBX Biosciences

Who Can Participate

Inclusion Criteria

Is an adult ≥18 years of age.
Has a documented diagnosis of post-surgical, chronic HypoPT or genetic, idiopathic, or autoimmune HypoPT for at least 12 months prior to screening.
Intact PTH level below the median value of the normal range
Minimum requirement for a dose of calcitriol ≥0.5 μg/day, or alfacalcidol ≥1.0 μg/day and (elemental) calcium ≥1000 mg/day for at least 12 weeks prior to screening. In addition, the doses of calcitriol, or alfacalcidol, and calcium should be stable for at least 3 weeks prior to screening.
Two (2) consecutive measurements of albumin-adjusted serum calcium at least 1 week apart within the range of 7.8 to 9.4 mg/dL (1.95 to 2.35 mmol/L). Key

Exclusion Criteria

Has a known history of pseudohypoparathyroidism
Clinically significant abnormal hematology, clinical chemistry, or coagulation.
Any disease that might affect calcium metabolism or calcium-phosphate homeostasis or PTH levels other than HypoPT, such as active endogenous hyperthyroidism;
Use of therapies affecting the calcium metabolism within 4 weeks prior to randomization
PTH or PTH-related protein drugs such as PTH(1-84) and PTH(1-34) within 5 weeks prior to screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Metairie?

Yes, this clinical trial (NCT07699471) has an active research site in Metairie, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypoparathyroidism Treatment Options in Metairie, LA

If you're searching for hypoparathyroidism treatment options in Metairie, LA, this clinical trial (NCT07699471) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Metairie research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced hypoparathyroidism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypoparathyroidism clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Metairie, LA

See all rheumatoid arthritis clinical trials recruiting in Metairie — not just this study.

Browse Rheumatoid Arthritis Trials in Metairie →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Metairie?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Metairie, LA